Results 51 to 60 of about 33,733 (216)
RENOVO-NF1 accurately predicts NF1 missense variant pathogenicity
Abstract The identification of a pathogenic variant in the NF1 gene is an important step in the diagnosis of the tumor-predisposing and developmental syndrome neurofibromatosis, and is increasingly important in the characterization of sporadic tumors, in which NF1 loss identifies specific biologic subtypes.
Emanuele Bonetti +4 more
openaire +3 more sources
Nf1 haploinsufficiency augments angiogenesis [PDF]
Mutations in the NF1 tumor-suppressor gene underlie neurofibromatosis type 1 (NF1), in which patients are predisposed to certain tumors such as neurofibromas and may associate with vascular disorder. Plexiform neurofibromas are slow growing benign tumors that are highly vascular and can progress to malignancy.
M, Wu, M R, Wallace, D, Muir
openaire +2 more sources
Somatic Double Inactivation of NF1 Associated with NF1-Related Pectus Excavatum Deformity
Neurofibromatosis type 1 (NF1) is a neurocutaneous genetic disorder with a broad spectrum of associated signs and symptoms, including skeletal anomalies. The association of NF1 with anterior chest wall deformities has been recently reported, especially the pectus excavatum (PE). Over the years, several authors have suggested loss of heterozygosity (LOH)
Cristina Chelleri +19 more
openaire +2 more sources
ABSTRACT This study proposes a novel double‐column vapor recompression heat pump (DCVRHP) distillation process for separating ternary wide‐boiling‐range mixtures under two different vapor conditions: n‐hexane/n‐heptane/n‐octane using low pressure steam and n‐hexanol/n‐octanol/n‐decanol using high pressure steam.
Zeyang Li +4 more
wiley +1 more source
Background There is limited population-based data on Neurofibromatosis type 1 (NF1) in North America. We aimed to develop and validate algorithms using administrative health data and electronic medical records (EMRs) to identify individuals with NF1 in ...
Carolina Barnett +5 more
doaj +1 more source
ABSTRACT CDK4/6 inhibitors combined with endocrine therapy are the standard first‐line treatment for hormone receptor‐positive (HR+) HER2‐negative metastatic breast cancer. However, a substantial proportion of patients experience early disease progression in routine practice. Clinicians currently lack practical tools at treatment initiation to identify
Mobina Shrestha +3 more
wiley +1 more source
Attention Deficit Predicts Intellectual Functioning in Children with Neurofibromatosis Type 1
Aims. Attention deficit hyperactivity disorder (ADHD) is one of the most frequent neurocognitive impairments in neurofibromatosis type 1 (NF1) and a well-known risk factor for intellectual dysfunction in general.
Magdalena Heimgärtner +5 more
doaj +1 more source
Abstract Neural crest cells are a transient cell population that emerges from the dorsal neural tube during neurulation and migrates extensively throughout the embryo. Among their diverse derivatives, glial cells (such as Schwann and satellite ganglionic cells) and melanocytes represent two major lineages. In vitro studies suggested they share a common
Chaya Kalcheim
wiley +1 more source
Precision therapies for genetic epilepsies in 2025: Promises and pitfalls
Abstract By targeting the underlying etiology, precision therapies offer an exciting paradigm shift to improve the stagnant outcomes of drug‐resistant epilepsies, including developmental and epileptic encephalopathies. Unlike conventional antiseizure medications (ASMs) which only treat the symptoms (seizures) but have no effect on the underlying ...
Shuyu Wang +3 more
wiley +1 more source
Unilateral Yasunari nodule-like appearance in a patient without neurofibromatosis type 1
Introduction: Yasunari nodules are choroidal lesions characterized by bright, poorly demarcated multiple lesions detected through near-infrared reflectance imaging and are considered diagnostic for neurofibromatosis type 1 (NF1).
Hamit Ali +5 more
doaj +1 more source

